Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV003468118 | SCV004196669 | likely pathogenic | Fanconi anemia complementation group C | 2023-06-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004364767 | SCV005032518 | pathogenic | Hereditary cancer-predisposing syndrome | 2023-10-26 | criteria provided, single submitter | clinical testing | The c.169delT pathogenic mutation, located in coding exon 2 of the FANCC gene, results from a deletion of one nucleotide at nucleotide position 169, causing a translational frameshift with a predicted alternate stop codon (p.S57Lfs*25). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |